M&A Deal Summary

Bio-Techne Acquires Quad Technologies

On June 7, 2018, Bio-Techne acquired life science company Quad Technologies

Acquisition Highlights
  • This is Bio-Techne’s 6th transaction in the Life Science sector.
  • This is Bio-Techne’s 10th transaction in the United States.
  • This is Bio-Techne’s 2nd transaction in Massachusetts.

M&A Deal Summary

Date 2018-06-07
Target Quad Technologies
Sector Life Science
Buyer(s) Bio-Techne
Deal Type Add-on Acquisition
Advisor(s) Burns & Levinson (Legal)

Target

Quad Technologies

Beverly, Massachusetts, United States
QT Holdings Corp. is a biotechnological company. QT Holdings was founded in 2012 and is based in Beverly, Massachusetts.

Search 215,074 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Bio-Techne

Minneapolis, Minnesota, United States

Category Company
Founded 1976
Sector Life Science
Employees3,200
Revenue 1.2B USD (2024)
DESCRIPTION
Bio-Techne's corporate headquarters in Minneapolis, Minnesota.
Bio-Techne's corporate headquarters in Minneapolis, Minnesota.

Bio-Techne is a life sciences company that provides bioactive tools and resources for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. Bio-Techne was founded in 1976 and is based in Minneapolis, Minnesota.


DEAL STATS #
Overall 11 of 18
Sector: Life Science M&A 6 of 11
Type: Add-on Acquisition M&A Deals 11 of 17
State: Massachusetts M&A 2 of 3
Country: United States M&A 10 of 15
Year: 2018 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-02 Atlanta Biologicals

Lawrenceville, Georgia, United States

Atlanta Biologicals, Inc. is a provider of cell culture sera, media and reagents for the life science research market. Atlanta Biologicals, Inc. was founded in 1992 and is based in Lawrenceville,Georgia.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-25 Exosome Diagnostics

Waltham, Massachusetts, United States

Exosome Diagnostics is a developer and commercializing revolutionary, biofluid-based diagnostics to deliver personalized precision healthcare. Exosome Diagnostics is based in Waltham, Massachusetts.

Buy $250M